Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
NCT00000517Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 1985
- Primary completion
- Jun 1991
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of warfarin in Atrial fibrillation (AFib) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Incidence of non-hemorrhage stroke at 2.2 years. Started Jul 1985; status: completed.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00000517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000517.